Key Takeaways
- Cigna has filed an antitrust lawsuit against Bristol Myers Squibb and its subsidiary Celgene, alleging that they unlawfully extended the monopoly on the cancer drug Pomalyst (pomalidomide) through illegal ‘pay-for-delay’ tactics.
Bristol Myers Squibb’s Celgene defrauded the US Patent Office, filed baseless lawsuits and used illicit reverse-payment settlements to “unlawfully extend,...